Loading...
PXR Modulates the Prostate Cancer Cell Response to Afatinib by Regulating the Expression of the Monocarboxylate Transporter SLC16A1
SIMPLE SUMMARY: Many kinase inhibitors have been tested as potential alternatives for the treatment of castration-resistant prostate cancers. However, none of these clinical trials led to drug approval despite interesting responses. Our study reveals that genes involved in drug metabolism and their...
Na minha lista:
| Udgivet i: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8305337/ https://ncbi.nlm.nih.gov/pubmed/34298852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13143635 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|